Quick Q for my clarification [Design Issues]

posted by martin  – Austria, 2012-11-06 13:29 (4187 d 03:46 ago) – Posting: # 9510
Views: 4,535

Hi ElMaestro!

Thank you for your quick reply with my attempt to answer the questions:

I was told that this design is standard for this kind of studies (one test and 2 references) and I think that straightforward doubling the sequence was intuitive with the aim to decrease the number of subjects (no power calculations available)

No idea regarding the intra-subject variability but this information may be important for planning upcoming studies

Scaling would be definitely an option if it turns out that the CV>30% (it's a NON-GXP study)

hope this helps

Martin

Complete thread:

UA Flag
Activity
 Admin contact
22,993 posts in 4,828 threads, 1,659 registered users;
66 visitors (0 registered, 66 guests [including 4 identified bots]).
Forum time: 18:15 CEST (Europe/Vienna)

So far as I can remember,
there is not one word in the Gospels
in praise of intelligence.    Bertrand Russell

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5